Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void?
暂无分享,去创建一个
[1] S. Kudoh,et al. Erythromycin treatment in diffuse panbronchiolitis. , 1998, Current opinion in pulmonary medicine.
[2] K. Tracey,et al. EGCG stimulates autophagy and reduces cytoplasmic HMGB1 levels in endotoxin-stimulated macrophages. , 2011, Biochemical pharmacology.
[3] Malina A. Bakowski,et al. Autophagy Controls Salmonella Infection in Response to Damage to the Salmonella-containing Vacuole* , 2006, Journal of Biological Chemistry.
[4] Chi-Tang Ho,et al. Peracetylation as a Means of Enhancing in Vitro Bioactivity and Bioavailability of Epigallocatechin-3-Gallate , 2006, Drug Metabolism and Disposition.
[5] D. Nicolau,et al. Reduction of bacterial titers by low-dose aspirin in experimental aortic valve endocarditis , 1993, Infection and immunity.
[6] P. Cardona,et al. Ibuprofen therapy resulted in significantly decreased tissue bacillary loads and increased survival in a new murine experimental model of active tuberculosis. , 2013, The Journal of infectious diseases.
[7] Yuan-Kun Lee,et al. Effect of tea phenolics and their aromatic fecal bacterial metabolites on intestinal microbiota. , 2006, Research in microbiology.
[8] Gerard D. Wright,et al. A forward chemical screen identifies antibiotic adjuvants in Escherichia coli. , 2012, ACS chemical biology.
[9] Alimuddin Zumla,et al. The Host Battles Drug-Resistant Tuberculosis , 2014, Science Translational Medicine.
[10] M. Schaller,et al. Ciclopirox Olamine Treatment Affects the Expression Pattern of Candida albicans Genes Encoding Virulence Factors, Iron Metabolism Proteins, and Drug Resistance Factors , 2003, Antimicrobial Agents and Chemotherapy.
[11] V. Parpura,et al. Epigallocatechin Gallate (EGCG) Stimulates Autophagy in Vascular Endothelial Cells , 2013, The Journal of Biological Chemistry.
[12] S. Kudoh,et al. [Clinical effects of low-dose long-term erythromycin chemotherapy on diffuse panbronchiolitis]. , 1987, Nihon Kyobu Shikkan Gakkai zasshi.
[13] S. Maier,et al. Opioid Activation of Toll-Like Receptor 4 Contributes to Drug Reinforcement , 2012, The Journal of Neuroscience.
[14] Stig Bengmark,et al. Curcumin, An Atoxic Antioxidant and Natural NFκB, Cyclooxygenase-2, Lipooxygenase, and Inducible Nitric Oxide Synthase Inhibitor: A Shield Against Acute and Chronic Diseases. , 2006, JPEN. Journal of parenteral and enteral nutrition.
[15] B. C. Wong,et al. Aspirin inhibits the growth of Helicobacter pylori and enhances its susceptibility to antimicrobial agents , 2003, Gut.
[16] Erin E. Gill,et al. Antibiotic Adjuvants: Diverse Strategies for Controlling Drug-Resistant Pathogens , 2014, Chemical biology & drug design.
[17] B. Aggarwal,et al. Evidence That Curcumin Suppresses the Growth of Malignant Gliomas in Vitro and in Vivo through Induction of Autophagy: Role of Akt and Extracellular Signal-Regulated Kinase Signaling Pathways , 2007, Molecular Pharmacology.
[18] Y. Shirataki,et al. Diclofenac in the management of E. coli urinary tract infections. , 2006, In vivo.
[19] J. Karlowsky,et al. In Vitro Activity of Plazomicin against 5,015 Gram-Negative and Gram-Positive Clinical Isolates Obtained from Patients in Canadian Hospitals as Part of the CANWARD Study, 2011-2012 , 2014, Antimicrobial Agents and Chemotherapy.
[20] K. Tateda,et al. Azithromycin Inhibits Quorum Sensing in Pseudomonas aeruginosa , 2001, Antimicrobial Agents and Chemotherapy.
[21] G. Woodnutt,et al. Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent. , 2004, The Journal of antimicrobial chemotherapy.
[22] Elizabeth M. Hansen,et al. A versatile high throughput screening system for the simultaneous identification of anti-inflammatory and neuroprotective compounds. , 2010, Journal of Alzheimer's disease : JAD.
[23] C. Pothoulakis. Effects of Clostridium difficile Toxins on Epithelial Cell Barrier , 2000, Annals of the New York Academy of Sciences.
[24] R. Keast,et al. Antimicrobial, antioxidant and anti-inflammatory phenolic activities in extra virgin olive oil. , 2012, Current opinion in biotechnology.
[25] Anirban Bhunia,et al. Berberine targets assembly of Escherichia coli cell division protein FtsZ. , 2008, Biochemistry.
[26] Jessica M. A. Blair,et al. Multidrug efflux pumps in Gram-negative bacteria and their role in antibiotic resistance. , 2014, Future microbiology.
[27] J. H. Park,et al. The anti-inflammatory non-antibiotic helper compound diclofenac: an antibacterial drug target , 2009, European Journal of Clinical Microbiology & Infectious Diseases.
[28] F. Giuliano,et al. Epigallocatechin-Gallate Enhances the Activity of Tetracycline in Staphylococci by Inhibiting Its Efflux from Bacterial Cells , 2004, Antimicrobial Agents and Chemotherapy.
[29] M. Colombo,et al. Autophagy in intracellular bacterial infection. , 2009, Biochimica et biophysica acta.
[30] H. Dihazi,et al. Impact of the antiproliferative agent ciclopirox olamine treatment on stem cells proteome. , 2013, World journal of stem cells.
[31] D. Shin,et al. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. , 2009, Cell host & microbe.
[32] Y. You,et al. Antibacterial activity of Curcuma longa L. against methicillin‐resistant Staphylococcus aureus , 2005, Phytotherapy research : PTR.
[33] Ilir Jusufi,et al. Green tea as an effective antimicrobial for urinary tract infections caused by Escherichia coli , 2013, Front. Microbiol..
[34] P. Taylor,et al. Modulation of beta-lactam resistance in Staphylococcus aureus by catechins and gallates. , 2004, International journal of antimicrobial agents.
[35] L. Rice. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. , 2008, The Journal of infectious diseases.
[36] E. McBryde,et al. Low-dose aspirin and ibuprofen's sterilizing effects on Mycobacterium tuberculosis suggest safe new adjuvant therapies for tuberculosis. , 2013, The Journal of infectious diseases.
[37] F. García-Cánovas,et al. Antifolate Activity of Epigallocatechin Gallate against Stenotrophomonas maltophilia , 2005, Antimicrobial Agents and Chemotherapy.
[38] Z. Hasan,et al. Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis’ , 2013, BMC Infectious Diseases.
[39] R. Xavier,et al. Autophagy and the immune system. , 2012, Annual review of immunology.
[40] B. Wren,et al. Clostridium difficile Modulates Host Innate Immunity via Toxin-Independent and Dependent Mechanism(s) , 2013, PloS one.
[41] G. Nair,et al. Antimicrobial Activity of Curcumin against Helicobacter pylori Isolates from India and during Infections in Mice , 2009, Antimicrobial Agents and Chemotherapy.
[42] M. Pirmohamed,et al. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. , 2001, Clinical Cancer Research.
[43] S. Maier,et al. Evidence that opioids may have toll-like receptor 4 and MD-2 effects , 2010, Brain, Behavior, and Immunity.
[44] G. Amsden. Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions? , 2005, The Journal of antimicrobial chemotherapy.
[45] S. Dastidar,et al. Activity of diclofenac used alone and in combination with streptomycin against Mycobacterium tuberculosis in mice. , 2007, International journal of antimicrobial agents.
[46] D. Ojcius,et al. Ivermectin Inhibits Growth of Chlamydia trachomatis in Epithelial Cells , 2012, PloS one.
[47] Huan Yang,et al. A Major Ingredient of Green Tea Rescues Mice from Lethal Sepsis Partly by Inhibiting HMGB1 , 2007, PloS one.
[48] Ming Zhang,et al. Berberine in type 2 diabetes therapy: a new perspective for an old antidiarrheal drug? , 2012 .
[49] Yan Luo,et al. Ciclopirox induces autophagy through reactive oxygen species-mediated activation of JNK signaling pathway , 2014, Oncotarget.
[50] K. Zandi,et al. A Review on Antibacterial, Antiviral, and Antifungal Activity of Curcumin , 2014, BioMed research international.
[51] S. Louie,et al. Potential role of macrolide antibiotics in the management of cystic fibrosis lung disease , 2002, Current opinion in pulmonary medicine.
[52] K. Oh,et al. Inhibition of the Bacterial Surface Protein Anchoring Transpeptidase Sortase by Isoquinoline Alkaloids , 2004, Bioscience, biotechnology, and biochemistry.
[53] M. Minden,et al. Oral ciclopirox olamine displays biological activity in a phase I study in patients with advanced hematologic malignancies , 2014, American journal of hematology.
[54] Wei-zhong Yang,et al. Curcumin Inhibits TLR2/4-NF-κB Signaling Pathway and Attenuates Brain Damage in Permanent Focal Cerebral Ischemia in Rats , 2014, Inflammation.
[55] Elena Deych,et al. Markers of intestinal inflammation, not bacterial burden, correlate with clinical outcomes in Clostridium difficile infection. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[56] Lei Zhang,et al. Inhibitory effects of ivermectin on nitric oxide and prostaglandin E2 production in LPS-stimulated RAW 264.7 macrophages. , 2009, International immunopharmacology.
[57] E. Abraham,et al. Activation of AMPK attenuates neutrophil proinflammatory activity and decreases the severity of acute lung injury. , 2008, American Journal of Physiology - Lung cellular and Molecular Physiology.
[58] J. Lakey,et al. Effect of Divalent Cation Removal on the Structure of Gram-Negative Bacterial Outer Membrane Models , 2014, Langmuir : the ACS journal of surfaces and colloids.
[59] P. Taylor,et al. The beta-lactam-resistance modifier (-)-epicatechin gallate alters the architecture of the cell wall of Staphylococcus aureus. , 2007, Microbiology.
[60] C. Guzmán,et al. Inhibition of Pseudomonas aeruginosa virulence factors by subinhibitory concentrations of azithromycin and other macrolide antibiotics. , 1993, The Journal of antimicrobial chemotherapy.
[61] Youn-Chul Kim,et al. Synergistic antibacterial effect of curcumin against methicillin-resistant Staphylococcus aureus. , 2013, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[62] T. Shimamura,et al. Epigallocatechin gallate synergy with ampicillin/sulbactam against 28 clinical isolates of methicillin-resistant Staphylococcus aureus. , 2001, The Journal of antimicrobial chemotherapy.
[63] F. Vandenesch,et al. Glycerol monolaurate inhibits the production of beta-lactamase, toxic shock toxin-1, and other staphylococcal exoproteins by interfering with signal transduction , 1994, Journal of bacteriology.
[64] J. Buer,et al. Anti‐infective properties of epigallocatechin‐3‐gallate (EGCG), a component of green tea , 2013, British journal of pharmacology.
[65] J. Gustafson,et al. The effects of salicylate on bacteria. , 2000, The international journal of biochemistry & cell biology.
[66] H. Virgin,et al. Autophagy in immunity and inflammation , 2011, Nature.
[67] B. Han,et al. Curcumin attenuates Concanavalin A-induced liver injury in mice by inhibition of Toll-like receptor (TLR) 2, TLR4 and TLR9 expression. , 2012, International immunopharmacology.
[68] D. Kaul,et al. Vitamin D3-dependent pathway regulates TACO gene transcription. , 2003, Biochemical and biophysical research communications.
[69] T. Shimamura,et al. Mechanism of Synergy between Epigallocatechin Gallate and β-Lactams against Methicillin-Resistant Staphylococcus aureus , 2001, Antimicrobial Agents and Chemotherapy.
[70] M. Chan. Inhibition of tumor necrosis factor by curcumin, a phytochemical. , 1995, Biochemical pharmacology.
[71] Y. You,et al. Antimicrobial activity of berberine alone and in combination with ampicillin or oxacillin against methicillin-resistant Staphylococcus aureus. , 2005, Journal of medicinal food.
[72] Russell E. Lewis,et al. Synergistic Activity of Colistin plus Rifampin against Colistin-Resistant KPC-Producing Klebsiella pneumoniae , 2013, Antimicrobial Agents and Chemotherapy.
[73] Mike Tyers,et al. Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy. , 2011, Nature chemical biology.
[74] K. Grzes,et al. Synergy between novel antimicrobials and conventional antibiotics or bacteriocins. , 2012, Polish journal of microbiology.
[75] J. Karlowsky,et al. Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination with Activity Against Multidrug-Resistant Gram-Negative Bacilli , 2013, Drugs.
[76] V. Deretic. Autophagy in immunity and cell‐autonomous defense against intracellular microbes , 2011, Immunological reviews.
[77] W. Raether,et al. [Microbiological laboratory studies with ciclopiroxolamine (author's transl)]. , 1981, Arzneimittel-Forschung.
[78] D. Nicolau,et al. Influence of aspirin on development and treatment of experimental Staphylococcus aureus endocarditis , 1995, Antimicrobial agents and chemotherapy.
[79] M. Iranshahi,et al. The combination effect of curcumin with different antibiotics against Staphylococcus aureus , 2009 .
[80] N. Woodford,et al. Carbapenemase-producing Enterobacteriaceae and non-Enterobacteriaceae from animals and the environment: an emerging public health risk of our own making? , 2014, The Journal of antimicrobial chemotherapy.
[81] R. Guerrant,et al. Fecal lactoferrin, interleukin-1beta, and interleukin-8 are elevated in patients with severe Clostridium difficile colitis , 1997, Clinical and diagnostic laboratory immunology.
[82] A. Rogers,et al. Activation of AMPK Inhibits Cholera Toxin Stimulated Chloride Secretion in Human and Murine Intestine , 2013, PloS one.
[83] Takashi Morihara,et al. Curcumin Structure-Function, Bioavailability, and Efficacy in Models of Neuroinflammation and Alzheimer's Disease , 2008, Journal of Pharmacology and Experimental Therapeutics.
[84] D. Aronoff,et al. The Systemic Inflammatory Response to Clostridium difficile Infection , 2014, PloS one.
[85] S. Shah,et al. The effect of a component of tea (Camellia sinensis) on methicillin resistance, PBP2' synthesis, and beta-lactamase production in Staphylococcus aureus. , 1998, The Journal of antimicrobial chemotherapy.
[86] D. Lebeaux,et al. Full and Broad-Spectrum In Vivo Eradication of Catheter-Associated Biofilms Using Gentamicin-EDTA Antibiotic Lock Therapy , 2012, Antimicrobial Agents and Chemotherapy.
[87] N. Chainani-Wu. Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa). , 2003, Journal of alternative and complementary medicine.
[88] Don Changsom,et al. Investigation of the anti-inflammatory effect of Curcuma longa in Helicobacter pylori-infected patients. , 2010, International immunopharmacology.
[89] Mi-ran Kim,et al. Curcuma longa L. constituents inhibit sortase A and Staphylococcus aureus cell adhesion to fibronectin. , 2005, Journal of agricultural and food chemistry.
[90] P. Pristovsek,et al. Green tea catechins inhibit bacterial DNA gyrase by interaction with its ATP binding site. , 2007, Journal of medicinal chemistry.
[91] Hiroshi Sagara,et al. Escape of Intracellular Shigella from Autophagy , 2005, Science.
[92] S. Hamada,et al. Autophagy Defends Cells Against Invading Group A Streptococcus , 2004, Science.
[93] P. Schlievert,et al. Effect of glycerol monolaurate on bacterial growth and toxin production , 1992, Antimicrobial Agents and Chemotherapy.
[94] L. O’Neill,et al. Inhibition of nuclear factor kappaB by direct modification in whole cells--mechanism of action of nordihydroguaiaritic acid, curcumin and thiol modifiers. , 1998, Biochemical pharmacology.
[95] A. Tamer,et al. A New Effect of Acetylsalicylic Acid? Significantly Lower Prevalence of Nasal Carriage of Staphylococcus aureus Among Patients Receiving Orally Administered Acetylsalicylic Acid , 2006, Infection Control & Hospital Epidemiology.
[96] K. Norga,et al. Expanding roles for AMP‐activated protein kinase in neuronal survival and autophagy , 2009, BioEssays : news and reviews in molecular, cellular and developmental biology.
[97] D. Walker,et al. AMPK modulates tissue and organismal aging in a non-cell-autonomous manner. , 2014, Cell reports.
[98] V. Deretic,et al. Autophagy Is a Defense Mechanism Inhibiting BCG and Mycobacterium tuberculosis Survival in Infected Macrophages , 2004, Cell.
[99] Fusheng Yang,et al. Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo* , 2005, Journal of Biological Chemistry.
[100] M. Bassetti,et al. Eravacycline for the treatment of intra-abdominal infections , 2014, Expert opinion on investigational drugs.
[101] T. Shimamura,et al. Inhibition by epigallocatechin gallate (EGCg) of conjugative R plasmid transfer in Escherichia coli , 2001, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[102] J. Karlowsky,et al. Ceftazidime-Avibactam: a Novel Cephalosporin/β-lactamase Inhibitor Combination , 2013, Drugs.
[103] J. B. Kim,et al. Berberine suppresses proinflammatory responses through AMPK activation in macrophages. , 2009, American journal of physiology. Endocrinology and metabolism.
[104] J. Molnár,et al. Potential management of resistant microbial infections with a novel non-antibiotic: the anti-inflammatory drug diclofenac sodium. , 2007, International journal of antimicrobial agents.
[105] J. Girault,et al. A Single Ascending Dose Study of Epigallocatechin Gallate in Healthy Volunteers , 2003, The Journal of international medical research.
[106] Xuming Deng,et al. Ivermectin inhibits LPS-induced production of inflammatory cytokines and improves LPS-induced survival in mice , 2008, Inflammation Research.
[107] M. Suico,et al. Curcumin decreases toll-like receptor-2 gene expression and function in human monocytes and neutrophils. , 2010, Biochemical and biophysical research communications.
[108] B. Nambisan,et al. In Vitro Synergistic Effect of Curcumin in Combination with Third Generation Cephalosporins against Bacteria Associated with Infectious Diarrhea , 2014, BioMed research international.
[109] K. Hahm,et al. Protective Mechanism of Epigallocatechin‐3‐Gallate against Helicobacter pylori‐Induced Gastric Epithelial Cytotoxicity via the Blockage of TLR‐4 Signaling , 2004, Helicobacter.
[110] A. Yamaguchi,et al. Antibacterial and Antifungal Activities of New Acylated Derivatives of Epigallocatechin Gallate , 2012, Front. Microbio..
[111] I. Nakagawa,et al. Autophagy in innate immunity against intracellular bacteria. , 2006, Journal of biochemistry.
[112] Xiao-hui Yu,et al. Berberine protects against lipopolysaccharide-induced intestinal injury in mice via alpha 2 adrenoceptor-independent mechanisms , 2011, Acta Pharmacologica Sinica.
[113] Yongcheng Song,et al. Toward Repurposing Ciclopirox as an Antibiotic against Drug-Resistant Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae , 2013, PloS one.
[114] Wei-Jia Kong,et al. Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression. , 2010, Metabolism: clinical and experimental.
[115] Jianping Ye,et al. Efficacy of berberine in patients with type 2 diabetes mellitus. , 2008, Metabolism: clinical and experimental.
[116] C. Rock,et al. Evaluation of Epigallocatechin Gallate and Related Plant Polyphenols as Inhibitors of the FabG and FabI Reductases of Bacterial Type II Fatty-acid Synthase* , 2004, Journal of Biological Chemistry.
[117] K. Mazumdar,et al. The anti‐inflammatory drug Diclofenac retains anti‐listerial activity in vivo , 2008, Letters in applied microbiology.
[118] P. Pristovsek,et al. MD‐2 as the target of curcumin in the inhibition of response to LPS , 2007, Journal of leukocyte biology.
[119] G. Kaplan,et al. Metformin as adjunct antituberculosis therapy , 2014, Science Translational Medicine.
[120] T. Shimamura,et al. Inhibition of Penicillinase by Epigallocatechin Gallate Resulting in Restoration of Antibacterial Activity of Penicillin against Penicillinase-Producing Staphylococcus aureus , 2002, Antimicrobial Agents and Chemotherapy.
[121] H. Eckert,et al. [Pharmacokinetics and biotransformation of the antimycotic drug ciclopiroxolamine in animals and man after topical and systemic administration]. , 1981, Arzneimittel-Forschung.
[122] T. Chatsuwan,et al. Curcumin suppresses gastric NF-kappaB activation and macromolecular leakage in Helicobacter pylori-infected rats. , 2010, World journal of gastroenterology.
[123] E. Abraham,et al. AMP‐activated protein kinase enhances the phagocytic ability of macrophages and neutrophils , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[124] J. McNaught. On the Action of Cold or Lukewarm Tea on Bacillus Typhosus , 1906 .
[125] G. Peiji. Antibacterial Mechanisms of Berberine and Reasons for Little Resistance of Bacteria , 2011 .
[126] Xiaoyan Liu,et al. Role of berberine in anti-bacterial as a high-affinity LPS antagonist binding to TLR4/MD-2 receptor , 2014, BMC Complementary and Alternative Medicine.
[127] A. Ryan,et al. A Role for TLR4 in Clostridium difficile Infection and the Recognition of Surface Layer Proteins , 2011, PLoS pathogens.
[128] J. Dick,et al. Chelation of intracellular iron with the antifungal agent ciclopirox olamine induces cell death in leukemia and myeloma cells. , 2009, Blood.
[129] Sushil K. Jain,et al. Curcumin supplementation lowers TNF-alpha, IL-6, IL-8, and MCP-1 secretion in high glucose-treated cultured monocytes and blood levels of TNF-alpha, IL-6, MCP-1, glucose, and glycosylated hemoglobin in diabetic rats. , 2009, Antioxidants & redox signaling.
[130] V. Deretic,et al. Autophagy in Immune Defense Against Mycobacterium tuberculosis , 2006, Autophagy.
[131] R. Ueda,et al. Autophagic control of listeria through intracellular innate immune recognition in drosophila , 2008, Nature Immunology.
[132] A. Schimmer,et al. The repositioning of the anti‐fungal agent ciclopirox olamine as a novel therapeutic agent for the treatment of haematologic malignancy , 2011, Journal of clinical pharmacy and therapeutics.
[133] S. Mostowy. Autophagy and bacterial clearance: a not so clear picture , 2012, Cellular microbiology.
[134] B. Bay,et al. Epigallocatechin-3-Gallate (EGCG), a Green Tea Polyphenol, Stimulates Hepatic Autophagy and Lipid Clearance , 2014, PloS one.
[135] D. Phoenix,et al. Novel Antimicrobial Agents and Strategies: Phoenix/Novel Antimicrobial Agents and Strategies , 2014 .
[136] J. Gemery,et al. Aspirin treatment is associated with a significantly decreased risk of Staphylococcus aureus bacteremia in hemodialysis patients with tunneled catheters. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[137] Ming You,et al. TSC2 Integrates Wnt and Energy Signals via a Coordinated Phosphorylation by AMPK and GSK3 to Regulate Cell Growth , 2006, Cell.
[138] S. Horvath,et al. IL-32 is a molecular marker of a host defense network in human tuberculosis , 2014, Science Translational Medicine.
[139] T. Shimamura,et al. Epigallocatechin Gallate Synergistically Enhances the Activity of Carbapenems against Methicillin-Resistant Staphylococcus aureus , 2002, Antimicrobial Agents and Chemotherapy.
[140] P. Srimanote,et al. Inhibition of cAMP-Activated Intestinal Chloride Secretion by Diclofenac: Cellular Mechanism and Potential Application in Cholera , 2014, PLoS neglected tropical diseases.
[141] A. Pilotto,et al. A Curcumin‐Based 1‐Week Triple Therapy for Eradication of Helicobacter pylori Infection: Something to Learn From Failure? , 2007, Helicobacter.
[142] G. Cole,et al. The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse , 2001, The Journal of Neuroscience.
[143] G. Mahady,et al. Turmeric (Curcuma longa) and curcumin inhibit the growth of Helicobacter pylori, a group 1 carcinogen. , 2002, Anticancer research.
[144] I. Zündorf,et al. Plant-Derived Anti-Inflammatory Compounds: Hopes and Disappointments regarding the Translation of Preclinical Knowledge into Clinical Progress , 2014, Mediators of inflammation.
[145] Jae Heun Lee,et al. Metformin inhibits HMGB1 release in LPS‐treated RAW 264.7 cells and increases survival rate of endotoxaemic mice , 2011, British journal of pharmacology.
[146] B. Aggarwal,et al. Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials , 2012, The AAPS Journal.